Bulletin
Investor Alert

London Markets Close in:

Cyclerion Therapeutics Inc.

NAS: CYCN

GO
/marketstate/country/us

Market open

 --Real time quotes

May 17, 2022, 11:17 a.m.

/zigman2/quotes/207301221/composite

$

0.57

Change

+0.0001 +0.02%

Volume

Volume 26,536

Real time quotes

/zigman2/quotes/207301221/composite

Previous close

$ 0.57

$ 0.57

Change

+0.0001 +0.02%

Day low

Day high

$0.56

$0.59

Open

52 week low

52 week high

$0.50

$4.86

Open

Cheryl Gault

Cheryl Gault is Chief Operating Officer for Cyclerion Therapeutics, Inc. and VP-Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc.

Ms. Gault previously held the position of Head-Sales & Marketing at Genzyme Corp.

She received an undergraduate degree from Boston College.

Transactions

Date Shares Transaction Value

Officers and Executives

Dr. Peter M. Hecht
Chief Executive Officer & Director
Ms. Cheryl Gault
Chief Operating Officer
Ms. Anjeza Gjino
Chief Financial Officer
Mr. Kevin Durfee
Vice President-Information Technology & Facilities
Dr. Andreas Eugen Busch
Chief Scientific Officer
Dr. G. Todd Milne
Senior Vice President-Corporate Development
Dr. Jennifer Chickering
Vice President-Clinical Strategy
Ms. Marsha H. Fanucci
Chairman
Dr. Errol B. de Souza
Independent Director
Ms. Stephanie Lovell
Independent Director
Dr. Michael E. Mendelsohn
Independent Director
Dr. Ole Isacson
Independent Director
Mr. Terrance G. McGuire
Independent Director
Mr. George H. Conrades
Independent Director
Link to MarketWatch's Slice.